New York State Common Retirement Fund
TAK icon

New York State Common Retirement Fund’s Takeda Pharmaceutical TAK Stock Holding History

New York State Common Retirement Fund’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Hold
11,757
– – ﹤0.01% 2394
2026
Q1 		$218K Hold
11,757
– – ﹤0.01% 2206
2025
Q4 		$183K Buy
+11,757
New +$168K ﹤0.01% 2334
2024
Q3 		– Sell
-9,368
Closed -$121K – 3328
2024
Q2 		$121K Hold
9,368
– – ﹤0.01% 2655
2024
Q1 		$130K Hold
9,368
– – ﹤0.01% 2632
2023
Q4 		$134K Hold
9,368
– – ﹤0.01% 2618
2023
Q3 		$145K Buy
+9,368
New +$145K ﹤0.01% 2563

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

New York State Common Retirement Fund's TAK Position: Q2 2026 in Review

New York State Common Retirement Fund held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 11,757 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

New York State Common Retirement Fund first reported a position in TAK in Q3 2023 and has held it in 7 quarters since. The position peaked at $218K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • New York State Common Retirement Fund held 11,757 shares of Takeda Pharmaceutical worth $188K as of Q2 2026.
  • New York State Common Retirement Fund left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2394 holding.
  • New York State Common Retirement Fund first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 7 quarters since.
  • New York State Common Retirement Fund's Takeda Pharmaceutical position peaked at $218K in Q1 2026.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.